TempO-SNP

About BioSpyder Technologies

BioSpyder Technologies, founded in 2010 and headquartered in Carlsbad, California, commercializes the TempO-Seq™ platform, a novel targeted RNA sequencing assay. The technology differentiates itself by enabling direct analysis from crude lysates, offering high sensitivity down to 10pg input, and allowing massive sample multiplexing, which dramatically reduces per-sample cost and complexity. This positions the company as an enabler for large-scale, high-throughput transcriptomic studies in both research and potential diagnostic applications. The business model appears to be a mix of platform technology (assay kits/panels) and fee-for-service bioinformatics and sequencing services.